Showing 1021-1030 of 1395 results for "".
- ASCRS Officially Cancels Its Annual Meetinghttps://modernod.com/news/ascrs-officially-cancels-its-annual-meeting/2477401/The American Society of Cataract and Refractive Surgery (ASCRS) is cancelling its annual meeting originally scheduled for May 15-20 in Boston. Through a statement po
- Despite Impressive Data, FDA’s Coronavirus Vaccine Reviews Will Take Weeks, Not Days, Official Sayshttps://modernod.com/news/despite-impressive-data-fdas-coronavirus-vaccine-reviews-will-take-weeks-not-days-official-says/2478574/As leading COVID-19 vaccines post positive phase 3 data and near FDA submissions, the agency official in charge of reviewing vaccines is emphasizing transparency and patience during the high-stakes process, according to a FiercePharma
- ASRS Announces Virtual Annual Scientific Meeting July 24-26, 2020https://modernod.com/news/asrs-announces-virtual-annual-scientific-meeting-july-24-26-2020/2477759/Due to the COVID-19 pandemic, the American Society of Retina Specialists (ASRS) has decided to hold its annual meeting online. In a letter to membership, Timothy Murray, MD, MBA, ASRS President, and Philip Ferrone, MD, Program Chair, said that the ASRS Board of Directors has concluded that
- First Patient Treated in Multicenter Trial Examining Allotex TransForm Allogenic Refractive Lenticules for Treatment of Presbyopiahttps://modernod.com/news/first-patient-treated-in-multicenter-trial-examining-allotex-transform-allogenic-refractive-lenticules-for-treatment-of-presbyopia/2479889/Start-up ophthalmic device company Allotex announced the commencement of a European multicenter trial for its investigational TransForm allogenic refractive lenticules for the treatment of presbyopia. The treatment was performed on Thursday by Arthur Cummings, MB ChB, FCS(SA), MMed(Ophth)
- FDA Officially Shifts to One-Trial Standard for New Drug Approvalshttps://modernod.com/news/fda-officially-shifts-to-one-trial-standard-for-new-drug-approvals/2485753/The FDA has announced a major change to its regulatory framework, formally establishing that a single well-designed pivotal clinical trial will be the new default basis for most drug and therapeutic approvals—replacing the long-standing expectation that two indepen
- The Vision Council Announces Dates for the 2021 Virtual Executive Summit: January 26–28, 2021https://modernod.com/news/the-vision-council-announces-dates-for-the-2021-virtual-executive-summit-january-26-28-2021/2478440/The Vision Council today announces that the
- UK Officials Defend Contingency Plan to Mix COVID-19 Vaccines in Rare Caseshttps://modernod.com/news/uk-officials-defend-contingency-plan-to-mix-covid-19-vaccines-in-rare-cases/2478710/According to a guidance update on December 31, the UK government will allow people to be given doses of different COVID-19 vaccines under certain circumstances, despite a lack of evidence about the extent of immunity offered by such mixing. The issue has sparked criticism after a report in Th
- Trump Health Official Says COVID Patients Should Not Re-Test. ‘It’s clogging up the system.’https://modernod.com/news/trump-health-official-says-covid-patients-should-not-re-test-its-clogging-up-the-system/2478038/The Trump administration plans to release guidance that non-hospitalized patients who test positive for COVID-19 do not need a second test to confirm they are clear of the virus, according to a FierceHealthcare
- Chinese Official Claims Fujifilm’s Avigan “Clearly Effective” in Treating COVID-19https://modernod.com/news/chinese-official-claims-fujifilms-avigan-clearly-effective-in-treating-covid-19/2477411/Results of clinical studies conducted in China suggest that Fujifilm’s Avigan (favipiravir) may be effective at treating patients with COVID-19. Zhang Xinmin, director of the China National Center for Biotechnology Development under the Ministry of Science and Technology, remarked “it
- Vit-Buckle Society Annual Meeting Cancelledhttps://modernod.com/news/vit-buckle-society-annual-meeting-cancelled/2477432/The Board of Trustees and the Executive Committee of the Vit-Buckle Society (VBS) said that its annual meeting, originally scheduled for March 26-28 in Miami, has been officially cancelled, according to a email sent to its members on Friday. Previously, the meeting was designated as postposed.